Posters & Publications

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Filter By:

Manuscript

Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein

View Manuscript
Manuscript

A Rationally Designed Humanized Antibody selective for Amyloid Beta oligomers in Alzheimer’s

View Manuscript
Manuscript

Supplemental Section - A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

View Manuscript
Poster

AAIC 2022 Poster - Distinguishing between amyloid-beta-directed antibodies: Ability of PMN310 to target toxic oligomers despite competing species

See Poster
Poster

AAN 2022 Poster - RACK1 Knockdown Alleviates TDP-43 Associated Global Translational Suppression in vitro, and Neurodegeneration in vivo

See Poster
Presentation

NDD 2022 Presentation - Selective Antibody Targeting of Pathogenic Proteins: maximizing target engagement, minimizing target distraction

View Presentation
Presentation

AD/PD 2022 Presentation - Optimizing vaccine design for Alzheimer’s disease: Selective targeting of computationally-derived conformational B cell epitopes of soluble amyloid-beta toxic oligomers

View Presentation
Presentation

AAIC 2021 Presentation - Selective Targeting of Intracellular Misfolded, Pathogenic TDP-43 with Rationally Designed Intrabodies

View Presentation
Poster

AAIC 2021 Poster - Conformational epitopes exposed on misfolded toxic forms of amyloid-beta, tau and alpha-synuclein directly contribute to their seeding activity

See Poster
Presentation

AAN 2020 Presentation - Achieving an optimal profile for immunotherapy of alpha-synucleinopathies: Rational generation of monoclonal antibodies selective for pathogenic forms of alpha-synuclein

View Presentation
Presentation

AAN 2020 Presentation - Generation of antibodies selective for misfolded disease-associated TDP-43

View Presentation
Presentation

AAIC 2020 Presentation - Rationally designed antibodies selective for pathogenic tau aggregates

View Presentation